California State Teachers Retirement System Purchases 14,270 Shares of Dolby Laboratories $DLB

California State Teachers Retirement System boosted its holdings in Dolby Laboratories (NYSE:DLB) by 24.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,518 shares of the electronics maker’s stock after acquiring an additional 14,270 shares during the quarter. California State Teachers Retirement System owned 0.08% of Dolby Laboratories worth $4,355,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in DLB. Boothbay Fund Management LLC grew its stake in Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares in the last quarter. Covestor Ltd lifted its stake in Dolby Laboratories by 6.0% in the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after purchasing an additional 175 shares in the last quarter. Fifth Third Bancorp lifted its stake in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares in the last quarter. State of Michigan Retirement System boosted its holdings in shares of Dolby Laboratories by 1.4% during the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after purchasing an additional 200 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its holdings in shares of Dolby Laboratories by 1.0% during the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after purchasing an additional 235 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Dolby Laboratories Stock Performance

DLB opened at $61.70 on Friday. Dolby Laboratories has a one year low of $48.26 and a one year high of $75.66. The stock has a market capitalization of $5.78 billion, a PE ratio of 26.26 and a beta of 0.80. The business’s 50 day moving average price is $52.82 and its 200 day moving average price is $58.49.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business had revenue of $305.00 million during the quarter, compared to analysts’ expectations of $311.96 million. During the same period in the prior year, the business posted $0.78 EPS. The company’s revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities research analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.

Dolby Laboratories announced that its board has initiated a share buyback program on Thursday, July 30th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is 61.28%.

Insider Transactions at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total transaction of $460,020.00. Following the completion of the transaction, the senior vice president directly owned 118,727 shares in the company, valued at $7,123,620. This trade represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer owned 81,490 shares in the company, valued at $4,618,853.20. This represents a 5.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 43,128 shares of company stock valued at $2,405,917 over the last three months. 37.93% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DLB has been the subject of several recent research reports. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, July 31st. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

Dolby Laboratories Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.